Combined therapy with probiotic VSL#3 and omega-3 fatty acids attenuates colonic injury and inflammation in chronic DNBS-induced colitis in mice (vol 69, pg 135, 2021)

İlktaç, Havvanur YoldaşKızıltan, GülLanpir, Aslı DevrimOzansoy, MehmetGünal, Mehmet Y.Toğay, Sine ÖzmenKeskin, İlknurÖzdemir, Ekrem M.Kılıç, Ulkan2024-11-082024-11-082022-04-010015-5497https://doi.org/10.3409/fb_70-1.05https://www.ingentaconnect.com/content/isez/fb/2022/00000070/00000001/art00005;jsessionid=2pur0h74hds4w.x-ic-live-01https://hdl.handle.net/11452/47613eninfo:eu-repo/semantics/openAccessCytokinesProbioticsOmega-3 fatty acidsInflammatory bowel diseasesColitisLife sciences & biomedicine - other topicsCombined therapy with probiotic VSL#3 and omega-3 fatty acids attenuates colonic injury and inflammation in chronic DNBS-induced colitis in mice (vol 69, pg 135, 2021)Correction000792884400005434370110.3409/fb_70-1.05